Siamab Therapeutics is a bio-pharmaceutical company developing therapies targeting cancers that express abnormal carbohydrates/glycans.
Location: United States, Massachusetts, Newton
Investors 3
Mentions in press and media 2
| Date | Title | Description | Source |
| 14.07.2014 | Siamab Therapeutics: New funding, new name, new direction in... | Siamab has identified highly specific antibodies that have the potential to not only kill tumor cell... | medcitynew... |
| - | Siamab Therapeutics: New funding, new name, new direction in... | Cambridge startup Siamab Therapeutics has changed up its direction, now developing monoclonal antibo... | medcitynew... |